Telomerase is a complex ribonucleoprotein enzyme that exhibits elevated activity in the majority of cases of human leukemia. We have previously shown that retroviral expression of the catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT), in human cord blood CD34 þ cells leads to an enhanced survival of mature hematopoietic cells. The mechanism for this pro-survival effect is not known. Here, we show that telomerase may play a role in leukemogenesis as a survival factor, independent of its role in maintaining telomere length. Retroviral expression of hTERT in the cytokine-dependent, human hematopoietic progenitor cell line, TF-1, resulted in the survival of cells following the withdrawal of cytokine, with protection from apoptosis, but did not promote unlimited replicative potential. This hTERT-mediated effect on cell survival does not involve Bcl-2 family members, results in accumulation of cells in G1 and appears to operate via autocrine expression of IL-3 and activation of the p53/p21 pathway. Survival in the absence of cytokine stimulation was also observed following retroviral expression of hTERT in normal cord blood CD34 þ cells. This study demonstrates a novel pro-survival role for hTERT and may have important implications for the role of hTERT in the pathogenesis of leukemia and drug resistance.
Introduction
The expression of telomerase is often a hallmark of leukemia cells. 1 Telomerase activity is elevated in approximately 75% of cases of acute leukemia 2, 3 and, in general, the prognosis is poorer for patients with high levels of telomerase activity compared to those with low telomerase activity. [2] [3] [4] [5] The role of telomerase within stem cells, hematopoietic progenitor cells and cancer has traditionally been thought to provide genomic stability through stabilization of telomeres and maintenance of proliferative potential. 6 However, recent studies indicate that telomerase plays an active role beyond net telomere elongation in promoting cell growth and survival. 7 While ectopic expression of human telomerase reverse transcriptase (hTERT) extends the replicative life span of some mesenchymal cells, 8, 9 such an effect within hematopoietic cells has not been observed. We have previously shown that retroviral expression of hTERT in human cord blood (CB) CD34 þ stem/progenitor cells does not alter the replicative potential of these cells but does lead to an enhanced survival of mature hematopoietic cells. 10 The aim of this study was to investigate the nature of this prosurvival role for hTERT in hematopoietic progenitor cells. To do this we have utilized a cell-line model of human hematopoietic progenitor cells, TF-1. 11 These cells are dependent on cytokine stimulation for their growth and, while they do express endogenous telomerase activity, this activity decreases following cytokine withdrawal. 12 Human telomerase reverse transcriptase was retrovirally expressed in TF-1 cells and the effect on survival following cytokine withdrawal assessed. Following the removal of cytokine an enhanced survival of hTERTtransduced cells was observed, with protection from apoptosis. Furthermore, overexpression of hTERT altered the cell cycle status of TF-1 cells, preventing them from exiting the cell cycle following cytokine withdrawal. The fact that upregulation of hTERT can overcome cytokine dependence for survival of hematopoietic progenitor cells and also perturb cell cycle dynamics has implications for the role of hTERT in normal hematopoiesis and also in the pathogenesis of leukemia.
Materials and methods

Construction of retroviral vector
The LuvTI2G bicistronic retrovirus was constructed in collaboration with the Geron Corporation and contained the fulllength hTERT coding sequence from pGRN145 13 cloned into the Moloney Murine Leukemia Virus-based retroviral vector backbone, pLuv.
14 LuvTI2G co-expressed hTERT and the green fluorescent protein (GFP) while the control retrovirus, LuvGM, expressed GFP alone. Stable amphotropic retroviral producer cells were derived (using the GP þ Env-AM12 cell line) and the retroviral titer measured as previously described. 15, 16 Typical titers for the vector preparations were: LuvGM 1 Â 10 6 i.u./ml and LuvTI2G 1 Â 10 5 i.u./ml. The LuvGM supernatant was routinely diluted 1:10 to allow a comparable MOI with LuvTI2G. The expression of catalytically active hTERT by the LuvTI2G retrovirus was confirmed by its ability to immortalize transduced BJ foreskin fibroblast cells (data not shown). 8 Generation of hTERT-transduced TF-1 clonal cell lines TF-1 cells were obtained from the ATCC and maintained as previously described in RPMI/10% FCS plus 1 ng/ml of IL-3 (R&D Systems, Minneapolis, MN, USA). 11, 17 The TF-1 cell-line was re-cloned before retroviral transduction. Cells were retrovirally transduced with serum-free supernatant containing either the LuvTI2G or LuvGM retrovirus. Three days post-transduction cells were placed into Methylcellulose culture and 10 days later colonies expressing GFP were identified using fluorescence microscopy, plucked and transferred to 48-well plates for expansion in the presence of IL-3. Clones were screened by flow cytometry for GFP expression and all clones selected were 498% GFP þ .
Immunoblot detection
Western blot analysis was performed as previously described, 18 with 50 mg of protein loaded on 10% SDS-PAGE gels for p21 and p53 protein detection. Expression of p21 and p53 proteins was determined by immunoblotting using antibodies against p21 (BD Pharmingen, San Diego, CA, USA) and p53 (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Reverse transcriptase polymerase chain reaction
Reverse transcriptase polymerase chain reaction (RT-PCR) was used to examine RNA expression of IL-3 and p21 in hTERTtransduced TF-1 cells. 19 Total RNA was isolated using Trizol (Invitrogen, Auckland, New Zealand) and 2 mg used for cDNA synthesis. Polymerase chain reaction amplification conditions were: 941C for 5 min; 25 cycles at 941C for 1 min, 601C for 1 min, and 721C for 1.5 min; 721C for 10 min. The primer pairs (20 pmol Cell cycle analysis Propidium iodide staining. Following culture of cells in the presence or absence of IL-3, cells were harvested and resuspended in buffer (1% BSA, 0.01% sodium azide in phosphate-buffered saline (PBS)) containing 25 mg/ml propidium iodide p1 (Sigma, St Louis, MO, USA) and analyzed by flow cytometry. 22 Ki-67 staining. The presence of quiescent cells was examined using a modified flow cytometry assay. 23 Briefly, control or hTERT-transduced TF-1 cells (1 Â 10 5 ) were cultured in 1 ml of RPMI/10% FCS in the presence or absence of 1 ng/ml of IL-3 for 1, 2, 3 or 6 days. Cells were fixed with 1 ml of 1% formaldehyde (Polysciences, Warrington, PA, USA) for 30 min on ice, then incubated for 15 mins at room temperature with 1 ml of permeabilization buffer (0.5% Triton X-100 in PBS; Roche, Mannheim, Germany). Cells were then incubated on ice for 45 min with 20 ml of PE-conjugated mouse anti-Ki-67 monoclonal antibody (BD Pharmingen), washed once in PBS/0.1% FCS and resuspended in 0.5 ml of washing buffer with 0.5 ng of 7-aminoactinomycin D (7AAD; Molecular Probes, Eugene, USA). Flow cytometric analysis was performed on a FACSCalibur cytometer (BD) and data analysed using the CellquestProt program. For each sample, electronic gating was performed on the intact cell population. The cell cycle status of viable retrovirally transduced TF-1 cells was determined by Ki-67 expression and 7AAD signal intensity.
BrdU staining. A bromodeoxyuridine (BrdU) kit (BD Pharmingen) was used to perform BrdU pulse labelling experiments to examine the presence of cells in S-phase. Following culture of control or hTERT-transduced cells in the presence or absence of IL-3 for 1, 2, 3 or 6 days cells were 'pulsed' with 10 mM BrdU for 1 h at 371C. Cells were processed according to kit instructions and labelled with allophycocyanin (APC) conjugated mouse anti-human BrdU antibody and 7AAD, before analysis using the FACSCalibur cytometer (BD).
Retroviral expression of hTERT in cord blood progenitor cells
In order to retrovirally express hTERT in human CB progenitor cells a new high titre retrovirus was constructed by cloning the full-length coding region from the hEST 2 (hTERT) cDNA (generously provided by Dr Roger Reddel) 24 into the EcoRI/SalI site of the MIG-B4 (MSCV HoxB4 IRES GFP) retroviral vector (kindly provided by Dr Keith Humphries, with permission from Dr Robert Hawley). 25 This new retroviral vector was named MTIG (MSCV hTERT IRES GFP) and produced the same results as LuvTI2G when used to transduce TF-1 cells (data not shown). Stable retroviral producer cells were derived as already described, with typical titers for the vector preparations being: MIG 3 Â 10 6 i.u./ml and MTIG 2 Â 10 6 i.u./ml. Cord blood that did not meet the criteria for banking, and was therefore available for research purposes, was obtained from the BMDI Cord Blood Bank, Melbourne, Australia, with approval from the RCH Ethics in Human Research Committee. A population enriched for CD34 þ cells was transduced with the MIG or MTIG retrovirus as described. 10, 26 In brief, CB CD34 þ cells were pre-stimulated for 3 days with IL-3 þ Flt3 ligand under serum-free conditions, transduced with retroviral supernatant and GFP þ cells FACS sorted 48 h later. GFP þ cells were then grown in the presence of a cocktail of cytokines (IL-3, IL-6, SCF, EPO, TPO) (R&D Systems) for 1 week, before being collected and washed twice with PBS. Cells were then replated at a density of 4 Â 10 5 cells/ml in serum-free BIT media (StemCell Technologies, Vancouver, Canada) 10 in the absence of any cytokines. Cell cycle analysis using propidium iodide staining was performed on days 3, 6 and 10 post-cytokine withdrawal. This experiment was repeated twice, with similar results.
Results and discussion
Generation of hTERT-transduced TF-1 clonal cell lines
Three clones each transduced with either LuvTI2G or LuvGM, and derived from the same parental TF-1 clone were maintained and examined in the following study. Western-blot analysis confirmed the expression of hTERT protein in hTERT-transduced hTERT promotes progenitor cell survival in the absence of cytokines S Li et al TF-1 cells, and Flow-FISH analysis demonstrated that retroviral expression of hTERT in TF-1 cells resulted in a nearly fourfold increase in telomere length (see Figure 1 of Supplementary Information). These molecular analyses confirm the retroviral expression of catalytically active hTERT in the hTERT-transduced clonal lines. Flow cytometry analysis revealed no significant difference in the expression of CD34, CD33 or CD38 between control and hTERT-transduced cells, either in the presence or absence of cytokine (data not shown).
Overexpression of hTERT allows cells to survive but does not promote unlimited replicative potential of TF-1 cells
We examined whether overexpression of hTERT altered the replicative potential of TF-1 cells. Cell growth was assessed by performing viable cell counts on retrovirally transduced TF-1 cells seeded at a density of 1 Â 10 5 cells per ml in 1 ml medium 3 and 7 days prior in the presence or absence of IL-3 ( Figure 1 ). In the presence of IL-3 cell number increased exponentially, with no difference between control and hTERT-transduced cells. Following 7 days in the absence of IL-3 the average number of viable control cells decreased to less than half the number of cells originally plated. In contrast, the number of viable hTERTtransduced cells increased by twofold at day 3 and 2.3-fold at day 7 without cytokine; however, exponential cell growth was not observed. The mechanism whereby this initial twofold increase in cell number was mediated is not yet known. These results reveal that overexpression of hTERT leads to an enhanced survival of TF-1 cells in the absence of cytokine but does not lead to unlimited replicative potential of these cells.
To directly examine this apparent pro-survival effect of hTERT, we investigated the effect of hTERT on cell death, assessed using Trypan blue staining, following the withdrawal of cytokine. In the presence of IL-3 fewer than 8% of control and hTERT-transduced cells stained positive for Trypan blue. After 3 days without cytokine 7772% of control cells stained positive for Trypan blue compared with only 3971% of hTERTtransduced cells (n ¼ 4 experiments, each with three clones; Po0.001). By day 7 the proportion of Trypan blue positive cells was 9076% and 5077%, respectively (n ¼ 3 experiments, each with three clones; Po0.05). These results indicate a protective effect of hTERT from cell death induced by cytokine withdrawal. There are at least three possible reasons why an enhanced survival of cells may be observed. This includes an effect on apoptotic pathways, an effect on cell cycle mechanisms and/or the establishment of paracrine or autocrine cytokine loops. Experiments were, therefore, performed to investigate the effect of retroviral expression of hTERT on apoptosis and cell cycle functions of TF-1 cells and the possibility of endogenous cytokine signalling.
Overexpression of hTERT protects cells from apoptosis induced by cytokine withdrawal
Following the withdrawal of cytokine from TF-1 cells a large proportion of control cells displayed membrane blebbing, a typical morphological appearance of cells undergoing apoptosis (data not shown). Annexin-V staining was performed to determine if the cell death observed was likely to have occurred via apoptosis. Figure 2a shows the flow cytometry profile for a representative experiment where one clone each of control and hTERT-transduced TF-1 cells were stained with Annexin-V-PE 
cytokine 80% of control cells were Annexin-V positive compared to only 20% of hTERT-transduced cells. Figure 2b shows combined data for all three clonal cell lines. Some clonal variation was observed, however an average of threefold more Annexin-V positive cells was observed in control cells compared to hTERT-transduced TF-1 cells following cytokine withdrawal for 7 days. Overexpression of hTERT significantly decreased the proportion of Annexin-V positive cells following withdrawal of cytokine, suggesting an anti-apoptotic role for hTERT in factor-dependent TF-1 cells. Expression of Bcl-2 is responsible for the survival observed in a murine factor dependent hematopoietic cell line following the removal of cytokine 27 and overexpression of Bcl-2 in human cancer cells results in increased levels of telomerase activity. 28 We, therefore, investigated whether the protection from apoptosis of hTERT-transduced TF-1 cells was mediated via upregulation of Bcl-2 or members of the Bcl-2 family of proteins. 29 Western-blot analysis revealed that there was no difference in the expression pattern of Bcl-2, Bcl-XL or Mcl-1 between control and hTERT-transduced TF-1 cells, in the presence or absence of IL-3 (see Figure 2 Supplementary Information). These results indicate that survival observed in hTERT-transduced cells following the removal of cytokine was not mediated via members of the Bcl-2 family examined. Furthermore, despite the interaction that has been observed between hTERT and AKT, 30 no evidence was obtained for enhanced survival being mediated via expression of phosphorylated AKT (Figure 2 Supplementary Information).
Together these results indicate that overexpression of hTERT protects TF-1 cells from apoptosis induced by cytokine withdrawal. The anti-apoptotic mechanism used to mediate this survival remains to be elucidated.
Overexpression of hTERT alters the cell cycle status of cells
To examine more closely the cell survival response of hTERTtransduced TF-1 cells, cells were deprived of cytokine for 3 days before the re-introduction of IL-3. Following the addition of IL-3, surviving control cells responded immediately and cell number increased exponentially over the following week. Unexpectedly, and in contrast, hTERT-transduced cells showed a delayed response to the addition of IL-3 and cell number increased at a more modest rate. At 1 week following the addition of IL-3 the number of control cells had increased on average by 72718-fold compared with only 2475-fold for hTERT-transduced TF-1 cells (n ¼ 3 experiments, each using three clones; Po0.05). This finding suggests that overexpression of hTERT rendered the transduced cells less responsive to the proliferative signals induced by the addition of exogenous cytokine.
Cell cycle experiments were performed to investigate whether this change in responsiveness to cytokine stimulation may be due to alterations in cell cycle status induced by hTERT. Retrovirally transduced TF-1 cells were grown for 3 or 6 days in the absence of cytokine and cell-cycle status assessed by staining cells with PI. Figure 3a shows the typical flow cytometry profile observed, where by days 3 and 6 following cytokine withdrawal 58 and 91% of control cells were in subG0 (dead), compared to only 1.3 and 8.5% of hTERT-transduced cells, respectively. Data from pooled experiments is shown in Figure 3b . Following cytokine withdrawal for 6 days significantly more control cells were in subG0 compared to hTERT-transduced cells, while an increased proportion of hTERT-transduced cells remained in G0/G1, compared to control cells.
BrdU pulse-labelling experiments were performed to examine this effect on cell cycle more closely. Cytokine was removed from cell cultures and cells examined on days 1, 2, 3 and 6 by BrdU pulse labelling assessed by flow cytometry. The flow cytometry profile from a representative experiment is shown in Figure 4a , with pooled data shown in Figure 4b . Only intact cells were gated on for this analysis to enable cell cycle status of surviving cells to be examined. By the end of the first day without cytokine significantly more hTERT-transduced cells were in G0/G1 compared with control cells and this difference progressively increased over the period of 3 days. Following 3 days without cytokine nearly half as many hTERT-transduced cells were in S-phase compared to control cells, with apparently fewer hTERT-transduced cells in G2-/M-phase compared to control cells, although this result did not reach statistical significance. Very few control cells remained alive by day 6 however a similar trend was observed. These experiments demonstrate that overexpression of hTERT reduces the proportion of actively cycling cells following cytokine withdrawal.
Given the importance of quiescence within the hematopoietic stem cell compartment, 31 we sought to determine whether hTERT-transduced TF-1 cells were maintained in quiescence (G0) or G1-phase of the cell cycle in the absence of cytokine. Ki-67 and 7AAD staining were used to examine the proportion Overexpression of hTERT results in survival of human cord blood progenitor cells
To investigate whether the findings observed in the TF-1 cell line model are relevant to that which occurs in primary hematopoietic progenitor cells, a high-titer hTERT retrovirus, MTIG, was used to transduce a CD34 þ -enriched population of cells. hTERT promotes progenitor cell survival in the absence of cytokines S Li et al
Given that cells were maintained in ex vivo culture for 5 days before sorting, it is assumed that the population of cells transduced by the retrovirus represents a progenitor cell population, although this population will need to be characterized further in future experiments. Following the 1-week culture period during which transduced GFP þ cells were expanded in number, cells were washed thoroughly and replated into serumfree media in the absence of cytokine. Cell cycle analysis was performed on days 3, 6 and 10 post-cytokine withdrawal ( Figure 5 ). Following 10 days of ex vivo culture in the absence of exogenous cytokines 63% of control cells were in SubG0. In striking contrast, and paralleling the TF-1 results, only 10% of hTERT-transduced cells were in SubG0, with the predominant cell population residing in G0/G1. This finding is in accordance with our previously published study. 10 Experiments are ongoing to characterize the transduced progenitor cell populations and to further understand this observation. The current results do, however, confirm a pro-survival role for hTERT in normal primary CD34 þ cells, in addition to those observed in our leukemia cell line model.
Overexpression of hTERT alters the molecular profile of survival genes downstream of cytokine signalling
In experiments utilizing conditioned media from hTERTtransduced cells no evidence was obtained for the production of a soluble survival factor (data not shown). However, this type of analysis does not exclude induction of an autocrine cytokine (IL-3) loop being mediated via hTERT-overexpression; we therefore investigated the mRNA expression of IL-3 ( Figure 6a ). In the presence of IL-3 both control and hTERTtransduced TF-1 cells expressed IL-3 transcript. Following the withdrawal of cytokine for 3 days surviving control cells expressed only negligible levels of IL-3 transcript. In striking contrast, hTERT-transduced cells continued to express IL-3 mRNA, at a level similar to that observed in cells grown in the presence of IL-3. This finding indicates an effect of hTERT in upregulating transcription of the IL-3 gene (or preventing degradation of the IL-3 mRNA transcript), and is consistent with the notion that the pro-survival effect of hTERT following cytokine withdrawal may be mediated, at least in part, via autocrine signalling. In a manner analogous to CML CD34 þ cells, 20 the expression of IL-3 may, in fact, explain why significantly fewer hTERT-transduced TF-1 cells entered quiescence following cytokine withdrawal compared to control cells.
Within the IL-3 signalling pathway different mechanisms are used to inhibit apoptosis as opposed to that used to drive proliferation; upregulation of p21 expression is one of the downstream events in the general survival response elicited by hTERT promotes progenitor cell survival in the absence of cytokines S Li et al IL-3. 32 The expression of p21 was examined at both the mRNA ( Figure 6b ) and protein (Figure 6c) level. In the presence of IL-3 both control and hTERT-transduced TF-1 cells expressed p21. Following the withdrawal of cytokine for 3 days hTERTtransduced cells continued to express p21. In contrast, negligible levels of p21 were observed in surviving control cells. In addition to supporting the presence of an IL-3 autocrine loop, this expression of p21 in the hTERT-transduced cells is consistent with the observed accumulation of cells in G1, with decreased cells in S-phase. 33 This finding suggests that hTERT may allow cytokine-independent hematopoietic progenitor cell survival via p21 regulation of cell cycle. It is likely that this increase in p21 transcription was mediated via an increase in p53. 34 As Figure 6c shows, in the presence of IL-3 both control and hTERT-transduced cells expressed p53. Following the withdrawal of cytokine the level of p53 expression appeared to decrease in surviving control cells but remained at similar levels to that observed in the presence of IL-3 in hTERTtransduced cells. Thus, the effect of hTERT on cell cycle and survival appears to be mediated via upregulation of IL-3 mRNA expression, a modest increase in p53 protein expression and a marked upregulation of p21 expression.
These results implicate hTERT and its downstream mediator, p21, as playing an active role in the pathogenesis of leukemia. The increase in p21 observed in some cancers may impart cells with a survival advantage, and represents a potential target for cancer therapy. 35 Induction of cell cycle arrest via hTERT and the p53/p21 pathway may potentially allow cancer cells to remain dormant during chemotherapy, with the capacity to reemerge at a future date. Our findings suggest that inhibition of hTERT may improve drug sensitivity for the treatment of cancer.
The significance of the telomere extension observed in hTERT-transduced TF-1 cells is not yet known. Studies by others have demonstrated that the pro-survival activity of hTERT is independent of its enzymatic activity 36, 37 and that hTERT can contribute to tumor development independent of its telomereelongating activities. 38 Whether or not the telomere elongation observed in our study is necessary for survival and the effects on cell cycle remains to be seen.
In conclusion, this study suggests that activation of telomerase may be an integral aspect of the leukemogenic process, independent of its role in telomere maintenance. Our results implicate hTERT as playing a pro-active role in the leukemogenic process by altering cytokine responsiveness and obviating the need for cytokine stimulation for survival.
